Muscle wasting and early mobilization in acute respiratory distress syndrome

Clinics in Chest Medicine

Volumn 35, Issue 4, 2014, Pages 811-826

  Walsh, Christopher J ^a   Batt, Jane ^a   Herridge, Margaret S ^b   Dos Santos, Claudia C ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ARDS; Critical illness; Early rehabilitation; Intensive care unit; Muscle weakness; Neuromuscular disease

Indexed keywords

BORTEZOMIB; CLENBUTEROL;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; CLINICAL STUDY; DIAPHRAGM DISEASE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ERGOMETRY; HUMAN; HYPERGLYCEMIA; IMMOBILITY; INSPIRATORY MUSCLE TRAINING; INTENSIVE CARE UNIT; MOBILIZATION; MUSCLE ATROPHY; MUSCLE TRAINING; MUSCLE WEAKNESS; NEUROMUSCULAR ELECTRICAL STIMULATION; NONHUMAN; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT CARE; PATIENT SAFETY; PHENOTYPE; PHYSICAL EXAMINATION; PHYSIOTHERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SEPSIS; TREATMENT INDICATION; COMPLICATION; INTENSIVE CARE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EARLY AMBULATION; HUMANS; INTENSIVE CARE; MUSCLE WEAKNESS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84910004403     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2014.08.016     Document Type: Review

References (120)

1. Herridge M.S., Tansey C.M., Matte A., et al. Functional disability 5 years after acute respiratory distress syndrome. NEngl J Med 2011, 364(14):1293-1304. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21470008.
2. Herridge M.S., Cheung A.M., Tansey C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. NEngl J Med 2003, 348(8):683-693. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12594312.
3. Bercker S., Weber-Carstens S., Deja M., et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005, 33(4):711-715. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/15818093.
4. Fletcher S.N., Kennedy D.D., Ghosh I.R., et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003, 31(4):1012-1016. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12682465.
5. Deem S., Lee C.M., Curtis J.R. Acquired neuromuscular disorders in the intensive care unit. Am J Respir Crit Care Med 2003, 168(7):735-739. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/14522811.
6. Latronico N., Shehu I., Elisa S. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 2005, 11(4):381-390.
7. Levine S., Nguyen T., Taylor N., et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. NEngl J Med 2008, 358(13):1327-1335. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18367735.
8. Garnacho-Montero J., Amaya-Villar R., Garcia-Garmendia J.L., et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005, 33(2):349-354.
9. De Jonghe B., Bastuji-Garin S., Durand M.C., et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 2007, 35(9):2007-2015.
10. Schefold J.C., Bierbrauer J., Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. JCachexia Sarcopenia Muscle 2010, 1(2):147-157. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21475702.
11. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288(22):2859-2867. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12472328.
12. Stevens R.D., Dowdy D.W., Michaels R.K., et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007, 33(11):1876-1891. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17639340.
13. Paddon-Jones D., Sheffield-Moore M., Cree M.G., et al. Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. JClin Endocrinol Metab 2006, 91(12):4836-4841. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/16984982.
14. Batt J., dos Santos C.C., Cameron J.I., et al. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013, 187(3):238-246. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23204256.
15. de Jonghe B., Lacherade J.C., Sharshar T., et al. Intensive care unit-acquired weakness: risk factors and prevention. Crit Care Med 2009, 37(10 Suppl):S309-S315. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20046115.
16. Witt N.J., Zochodne D.W., Bolton C., et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99(1):176-184. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/1845860.
17. Bednarik J., Vondracek P., Dusek L., et al. Risk factors for critical illness polyneuromyopathy. JNeurol 2005, 252(3):343-351. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/15791390.
18. de Letter M.A., Schmitz P.I., Visser L.H., et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001, 29(12):2281-2286. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/11801825.
19. Latronico N., Nisoli E., Eikermann M. Muscle weakness and nutrition in critical illness: matching nutrient supply and use. Lancet Respir Med 2013, 1(8):589-590.
20. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64(8):1348-1353. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/15851721.
21. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. NEngl J Med 2001, 345(19):1359-1367. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/11794168.
22. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. NEngl J Med 2006, 354(5):449-461. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/16452557.
23. Hermans G., De Jonghe B., Bruyninckx F., et al. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2009, (1). CD006832. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19160304.
24. NICE-SUGAR Study Investigators, Finfer S., Chittock D.R., et al. Intensive versus conventional glucose control in critically ill patients. NEngl J Med 2009, 360(13):1283-1297. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19318384.
25. Garnacho-Montero J., Madrazo-Osuna J., Garcia-Garmendia J.L., et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001, 27(8):1288-1296. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/11511941.
26. Steinberg K.P., Hudson L.D., Goodman R.B., et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. NEngl J Med 2006, 354(16):1671-1684. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/16625008.
27. Hough C.L., Steinberg K.P., Taylor Thompson B., et al. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med 2009, 35(1):63-68. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18946660.
28. Meduri G.U., Golden E., Freire A.X., et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007, 131(4):954-963. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17426195.
29. Leatherman J.W., Fluegel W.L., David W.S., et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996, 153(5):1686-1690.
30. Papazian L., Forel J.M., Gacouin A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. NEngl J Med 2010, 363(12):1107-1116. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20843245.
31. Winkelman C. Inactivity and inflammation in the critically ill patient. Crit Care Clin 2007, 23(1):21-34. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17307114.
32. Nanas S., Kritikos K., Angelopoulos E., et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 2008, 118(3):175-181. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18355395.
33. Ali N.A., O'Brien J.M., Hoffmann S.P., et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008, 178(3):261-268. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18511703.
34. Tzanis G., Vasileiadis I., Zervakis D., et al. Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness. BMC Anesthesiol 2011, 11:14. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21703029.
35. De Jonghe B., Bastuji-Garin S., Sharshar T., et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation?. Intensive Care Med 2004, 30(6):1117-1121. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/14767593.
36. Connolly B.A., Jones G.D., Curtis A.A., et al. Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study. Crit Care 2013, 17(5):R229. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/24112540.
37. Stevens R.D., Marshall S.A., Cornblath D.R., et al. Aframework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009, 37(10 Suppl):S299-S308. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20046114.
38. Ferrando A.A., Paddon-Jones D., Wolfe R.R. Bed rest and myopathies. Curr Opin Clin Nutr Metab Care 2006, 9(4):410-415. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/16778570.
39. Wilcox M.E., Herridge M.S. Long-term outcomes in patients surviving acute respiratory distress syndrome. Semin Respir Crit Care Med 2010, 31(1):55-65. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20101548.
40. Kleyweg R.P., van der Meche F.G., Schmitz P.I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 1991, 14(11):1103-1109. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/1745285.
41. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111-117. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12091180.
42. Linacre J.M., Heinemann A.W., Wright B.D., et al. The structure and stability of the functional independence measure. Arch Phys Med Rehabil 1994, 75(2):127-132.
43. McHorney C.A., Ware J.E.J., Lu J.F., et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32(1):40-66.
44. Ruff R.L. Why do ICU patients become paralyzed?. Ann Neurol 1998, 43(2):154-155. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/9485055.
45. Allen D.C., Arunachalam R., Mills K.R. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy. Muscle Nerve 2008, 37(1):14-22. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17763454.
46. Carre J.E., Orban J.C., Re L., et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010, 182(6):745-751. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20538956.
47. Brealey D., Karyampudi S., Jacques T.S., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004, 286(3):R491-R497. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/14604843.
48. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360(9328):219-223.
49. Fredriksson K., Tjader I., Keller P., et al. Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS One 2008, 3(11):e3686. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18997871.
50. Picard M., Shirihai O.S., Gentil B.J., et al. Mitochondrial morphology transitions and functions: implications for retrograde signaling?. Am J Physiol Regul Integr Comp Physiol 2013, 304(6):R393-R406. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23364527.
51. Constantin D., McCullough J., Mahajan R.P., et al. Novel events in the molecular regulation of muscle mass in critically ill patients. JPhysiol 2011, 589(Pt 15):3883-3895. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21669975.
52. Tiao G., Hobler S., Wang J.J., et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. JClin Invest 1997, 99(2):163-168. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/9005983.
53. Jespersen J.G., Nedergaard A., Reitelseder S., et al. Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients. PLoS One 2011, 6(3):e18090. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21483870.
54. Puthucheary Z.A., Rawal J., McPhail M., et al. Acute skeletal muscle wasting in critical illness. JAMA 2013, 310(15):1591-1600. http://www.ncbi.nlm.nih.gov/pubmed/24108501.
55. Zhao J., Brault J.J., Schild A., et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007, 6(6):472-483. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18054316.
56. Wang X., Blagden C., Fan J., et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 2005, 19(14):1715-1722. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/16024660.
57. Sandri M., Sandri C., Gilbert A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
58. Talbert E.E., Smuder A.J., Min K., et al. Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant. JAppl Physiol (1985) 2013, 115(4):529-538. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23766499.
59. Masiero E., Agatea L., Mammucari C., et al. Autophagy is required to maintain muscle mass. Cell Metab 2009, 10(6):507-515. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19945408.
60. Hussain S.N., Mofarrahi M., Sigala I., et al. Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 2010, 182(11):1377-1386. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20639440.
61. Vanhorebeek I., Gunst J., Derde S., et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. JClin Endocrinol Metab 2011, 96(4):E633-E645. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21270330.
62. Rennie M.J. Anabolic resistance in critically ill patients. Crit Care Med 2009, 37(10 Suppl):S398-S399. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20046126.
63. Schiaffino S., Dyar K.A., Ciciliot S., et al. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013, 280(17):4294-4314. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23517348.
64. Stitt T.N., Drujan D., Clarke B.A., et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004, 14(3):395-403.
65. Chambers M.A., Moylan J.S., Reid M.B. Physical inactivity and muscle weakness in the critically ill. Crit Care Med 2009, 37(10 Suppl):S337-S346. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20046119.
66. Berg H.E., Larsson L., Tesch P.A. Lower limb skeletal muscle function after 6 wk of bed rest. JAppl Physiol (1985) 1997, 82(1):182-188.
67. Stevens J.E., Walter G.A., Okereke E., et al. Muscle adaptations with immobilization and rehabilitation after ankle fracture. Med Sci Sports Exerc 2004, 36(10):1695-1701.
68. Powers S.K., Smuder A.J., Criswell D.S. Mechanistic links between oxidative stress and disuse muscle atrophy. Antioxid Redox Signal 2011, 15(9):2519-2528. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21457104.
69. Fan E., Zanni J.M., Dennison C.R., et al. Critical illness neuromyopathy and muscle weakness in patients in the intensive care unit. AACN Adv Crit Care 2009, 20(3):243-253. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19638746.
70. Suhr F., Brenig J., Muller R., et al. Moderate exercise promotes human RBC-NOS activity, NO production and deformability through Akt kinase pathway. PLoS One 2012, 7(9):e45982. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23049912.
71. Jackson M.J. Control of reactive oxygen species production in contracting skeletal muscle. Antioxid Redox Signal 2011, 15(9):2477-2486. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21699411.
72. Lacomis D., Petrella J.T., Giuliani M. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998, 21(5):610-617.
73. Hamburg N.M., McMackin C.J., Huang A.L., et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol 2007, 27(12):2650-2656. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17932315.
74. Morris P.E. Moving our critically ill patients: mobility barriers and benefits. Crit Care Clin 2007, 23(1):1-20. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17307113.
75. Bailey P., Thomsen G.E., Spuhler V.J., et al. Early activity is feasible and safe in respiratory failure patients. Crit Care Med 2007, 35(1):139-145. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17133183.
76. Morris P.E., Goad A., Thompson C., et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 2008, 36(8):2238-2243. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18596631.
77. Needham D.M., Korupolu R., Zanni J.M., et al. Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project. Arch Phys Med Rehabil 2010, 91(4):536-542. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20382284.
78. Zeppos L., Patman S., Berney S., et al. Physiotherapy in intensive care is safe: an observational study. Aust J Physiother 2007, 53(4):279-283.
79. Thomsen G.E., Snow G.L., Rodriguez L., et al. Patients with respiratory failure increase ambulation after transfer to an intensive care unit where early activity is a priority. Crit Care Med 2008, 36(4):1119-1124. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18379236.
80. Needham D.M. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA 2008, 300(14):1685-1690. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18840842.
81. Perme C., Chandrashekar R. Early mobility and walking program for patients in intensive care units: creating a standard of care. Am J Crit Care 2009, 18(3):212-221. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19234100.
82. Jones C., Skirrow P., Griffiths R.D., et al. Rehabilitation after critical illness: a randomized, controlled trial. Crit Care Med 2003, 31(10):2456-2461. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/14530751.
83. Burtin C., Clerckx B., Robbeets C., et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 2009, 37(9):2499-2505. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19623052.
84. Gibson J.N., Smith K., Rennie M.J. Prevention of disuse muscle atrophy by means of electrical stimulation: maintenance of protein synthesis. Lancet 1988, 2(8614):767-770.
85. Routsi C., Gerovasili V., Vasileiadis I., et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care 2010, 14(2):R74. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/20426834.
86. Maffiuletti N.A., Roig M., Karatzanos E., et al. Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review. BMC Med 2013, 11:137. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23701811.
87. Vasilevskis E.E., Ely E.W., Speroff T., et al. Reducing iatrogenic risks: ICU-acquired delirium and weakness-crossing the quality chasm. Chest 2010, 138(5):1224-1233. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21051398.
88. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371(9607):126-134. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18191684.
89. Schweickert W.D., Pohlman M.C., Pohlman A.S., et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373(9678):1874-1882. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19446324.
90. Denehy L., Berney S. Physiotherapy in the intensive care unit. Phys Ther Rev 2006, 11(1):49-56.
91. Morris P.E., Herridge M.S. Early intensive care unit mobility: future directions. Crit Care Clin 2007, 23(1):97-110. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17307119.
92. Batt J., Dos Santos C.C., Herridge M.S. Muscle injury during critical illness. JAMA 2013, 310(15):1569-1570. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/24108459.
93. Varpula T., Valta P., Niemi R., et al. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand 2004, 48(6):722-731.
94. Putensen C., Zech S., Wrigge H., et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001, 164(1):43-49.
95. Cordioli R.L., Akoumianaki E., Brochard L. Nonconventional ventilation techniques. Curr Opin Crit Care 2013, 19(1):31-37. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23235544.
96. Tuchscherer D., Z'Graggen W.J., Passath C., et al. Neurally adjusted ventilatory assist in patients with critical illness-associated polyneuromyopathy. Intensive Care Med 2011, 37(12):1951-1961. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/22048718.
97. Martin A.D., Smith B.K., Davenport P.D., et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care 2011, 15(2):R84. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21385346.
98. Condessa R.L., Brauner J.S., Saul A.L., et al. Inspiratory muscle training did not accelerate weaning from mechanical ventilation but did improve tidal volume and maximal respiratory pressures: a randomised trial. JPhysiol 2013, 59(2):101-107.
99. Krzak A., Pleva M., Napolitano L.M. Nutrition therapy for ALI and ARDS. Crit Care Clin 2011, 27(3):647-659. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21742221.
100. Villet S., Chiolero R.L., Bollmann M.D., et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 2005, 24(4):502-509. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/15899538.
101. Martindale R.G., McClave S.A., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009, 37(5):1757-1761. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19373044.
102. Singer P., Berger M.M., Van den Berghe G., et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28(4):387-400. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19505748.
103. Ibrahim E.H., Mehringer L., Prentice D., et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002, 26(3):174-181. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12005458.
104. Casaer M.P., Mesotten D., Hermans G., et al. Early versus late parenteral nutrition in critically ill adults. NEngl J Med 2011, 365(6):506-517. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21714640.
105. Hermans G., Casaer M.P., Clerckx B., et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 2013, 1(8):621-629.
106. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice T.W., Wheeler A.P., Thompson B.T., Steingrub J., et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 2012, 307(8):795-803. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/22307571.
107. Needham D.M., Dinglas V.D., Morris P.E., et al. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med 2013, 188(5):567-576. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23805899.
108. Heidegger C.P., Berger M.M., Graf S., et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet 2013, 381(9864):385-393. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23218813.
109. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. NEngl J Med 1999, 341(11):785-792.
110. McClung J.M., Davis J.M., Wilson M.A., et al. Estrogen status and skeletal muscle recovery from disuse atrophy. JAppl Physiol (1985) 2006, 100(6):2012-2023. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/16497837.
111. Mukai R., Horikawa H., Fujikura Y., et al. Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice. PLoS One 2012, 7(9):e45048. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23028754.
112. Goncalves D.A., Silveira W.A., Lira E.C., et al. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt. Am J Physiol Endocrinol Metab 2012, 302(1):E123-E133. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/21952035.
113. Kline W.O., Panaro F.J., Yang H., et al. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. JAppl Physiol (1985) 2007, 102(2):740-747. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/17068216.
114. Ryall J.G., Lynch G.S. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting. Pharmacol Ther 2008, 120(3):219-232. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18834902.
115. Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013, 45(10):2121-2129. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/23665154.
116. Supinski G.S., Vanags J., Callahan L.A. Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction. Am J Physiol Lung Cell Mol Physiol 2009, 296(6):L994-L1001. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19376888.
117. Park J.W., Kim K.M., Oh K.J., et al. Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury. JTrauma 2009, 66(3):743-748. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19276748.
118. Agten A., Maes K., Thomas D., et al. Bortezomib partially protects the rat diaphragm from ventilator-induced diaphragm dysfunction. Crit Care Med 2012, 40(8):2449-2455. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/22809912.
119. Xiao Y., Yin J., Wei J., et al. Incidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysis. PLoS One 2014, 9(1):e87671. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/24489948.
120. Malkoc M., Karadibak D., Yildirim Y. The effect of physiotherapy on ventilatory dependency and the length of stay in an intensive care unit. Int J Rehabil Res 2009, 32(1):85-88. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/19011583.